drugset / Trial / NCT02569853

DFN-11 Injection in Episodic Migraine With or Without Aura

NCT02569853

Phase 3 Completed 268 enrolled Dr. Reddy's Laboratories Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

Safety and Efficacy of DFN-11 in patients with episodic migraines with or without aura.

Timeline

Start
2015-09-21
Primary completion
2017-05-30
Completion
2018-02-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Sumatriptan Unknown 3 mg Subcutaneous

Indications